Translational control protein 80 stimulates IRES-mediated translation of p53 mRNA in response to DNA damage

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Halaby, Marie Jo ^a   Li, Yan ^a   Harris, Benjamin R ^a   Jiang, Shuxia ^a   Miskimins, W Keith ^b   Cleary, Margot P ^a,c   Yang, Da Qing ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN P53; PUMA PROTEIN; RNA HELICASE; RNA HELICASE A; TRANSLATIONAL CONTROL PROTEIN 80; UNCLASSIFIED DRUG; ILF3 PROTEIN, HUMAN; INTERLEUKIN ENHANCER BINDING FACTOR 3; INTERNAL RIBOSOME ENTRY SITE;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENOTOXIC STRESS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; MCF 7 CELL LINE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA TRANSLATION; STRESS; UPREGULATION; MCF-7 CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS;

DNA DAMAGE; HUMANS; INTERNAL RIBOSOME ENTRY SITES; MCF-7 CELLS; NUCLEAR FACTOR 90 PROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84939124033     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/708158     Document Type: Article

References (44)

1. B. Vogelstein, D. Lane, and A. J. Levine, "Surfing the p53 network," Nature, vol. 408, no. 6810, pp. 307-310, 2000.
2. A. J. Giaccia and M. B. Kastan, "The complexity of p53 modulation: emerging patterns from divergent signals," Genes and Development, vol. 12, no. 19, pp. 2973-2983, 1998.
3. M. E. Ewen and S. J. Miller, "p53 and translational control," Biochimica et BiophysicaActa-Reviews on Cancer, vol. 1242, no. 3, pp. 181-184, 1996.
4. M.-J. Halaby and D.-Q. Yang, "p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics," Gene, vol. 395, no. 1-2, pp. 1-7, 2007.
5. R. Grover, M. M. Candeias, R. Fhraeus, and S. Das, "P53 and little brother p53/47: linking IRES activities with protein functions," Oncogene, vol. 28, no. 30, pp. 2766-2772, 2009.
6. J. Mosner, T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, and W. Deppert, "Negative feedback regulation of wild-type p53 biosynthesis," The EMBO Journal, vol. 14, no. 18, pp. 4442-4449, 1995.
7. L. Fu and S. Benchimol, "Participation of the human p53 3UTR in translational repression and activation following γ- irradiation," The EMBO Journal, vol. 16, no. 13, pp. 4117-4125, 1997.
8. D.-Q. Yang, M.-J. Halaby, and Y. Zhang, "The identification of an internal ribosomal entry site in the 5′-untranslated region of p53mRNA provides a novelmechanism for the regulation of its translation following DNA damage," Oncogene, vol. 25, no. 33, pp. 4613-4619, 2006.
9. A. C. Gingras, B. Raught, and N. Sonenberg, "eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation," Annual Review of Biochemistry, vol. 68, pp. 913-963, 1999.
10. D. Yang, G. J. Brunn, and J. C. Lawrence Jr., "Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR," FEBS Letters, vol. 453, no. 3, pp. 387-390, 1999.
11. I. Mothe-Satney, D. Yang, P. Fadden, T. A. J. Haystead, and J. C. Lawrence Jr., "Multiplemechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression," Molecular and Cellular Biology, vol. 20, no. 10, pp. 3558-3567, 2000.
12. C. U. T. Hellen and P. Sarnow, "Internal ribosome entry sites in eukaryotic mRNA molecules," Genes and Development, vol. 15, no. 13, pp. 1593-1612, 2001.
13. A. B. Sachs, "Cell cycle-dependent translation initiation: IRES elements prevail," Cell, vol. 101, no. 3, pp. 243-245, 2000.
14. M. Stoneley and A. E. Willis, "Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression," Oncogene, vol. 23, no. 18, pp. 3200-3207, 2004.
15. M. Holcik and N. Sonenberg, "Translational control in stress and apoptosis," Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 318-327, 2005.
16. K. W. Sherrill, M. P. Byrd, M. E. van Eden, and R. E. Lloyd, "BCL-2 translation is mediated via internal ribosome entry during cell stress,"The Journal of Biological Chemistry, vol. 279, no. 28, pp. 29066-29074, 2004.
17. N. H. Ungureanu, M. Cloutier, S. M. Lewis et al., "Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell death," The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15155-15163, 2006.
18. P. S. Ray, R. Grover, and S. Das, "Two internal ribosome entry sites mediate the translation of p53 isoforms," EMBO Reports, vol. 7, no. 4, pp. 404-410, 2006.
19. M. M. Candeias, D. J. Powell, E. Roubalova et al., "Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNAtranslation initiation," Oncogene, vol. 25, no. 52, pp. 6936-6947, 2006.
20. A. E. Sayan, J. P. Roperch, B. S. Sayan et al., "Generation of δTAp73 proteins by translation from a putative internal ribosome entry site," Annals of the New York Academy of Sciences, vol. 1095, pp. 315-324, 2007.
21. L. Montanaro, M. Calienni, S. Bertoni et al., "Novel dyskerinmediated mechanism of p53 inactivation through defective mRNA translation," Cancer Research, vol. 70, no. 11, pp. 4767-4777, 2010.
22. C. Bellodi, N. Kopmar, and D. Ruggero, "Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita," The EMBO Journal, vol. 29, no. 11, pp. 1865-1876, 2010.
23. L. Wedeken, P. Singh, and K.-H. Klempnauer, "Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA," The Journal of Biological Chemistry, vol. 286, no. 50, pp. 42855-42862, 2011.
24. A. Sharathchandra, R. Lal, D. Khan, and S. Das, "Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA," RNA Biology, vol. 9, no. 12, pp. 1429-1439, 2012.
25. D.-Y. Kim, W. Kim, K.-H. Lee et al., "hnRNP Q regulates translation of p53 in normal and stress conditions," Cell Death and Differentiation, vol. 20, no. 2, pp. 226-234, 2013.
26. R. Grover, A. Sharathchandra, A. Ponnuswamy, D. Khan, and S. Das, "Effect of mutations on the p53 IRES RNA structure: implications for de-regulation of the synthesis of p53 isoforms," RNA Biology, vol. 8, no. 1, 2011.
27. R. Grover, P. S. Ray, and S. Das, "Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms," Cell Cycle, vol. 7, no. 14, pp. 2189-2198, 2008.
28. D. Khan, A. Katoch, A. Das et al., "Reversible induction of translational isoforms of p53 in glucose deprivation," Cell Death and Differentiation, 2015.
29. R. J. Jackson, "Alternative mechanisms of initiating translation of mammalian mRNAs," Biochemical Society Transactions, vol. 33, no. 6, pp. 1231-1241, 2005.
30. M. Takagi, M. J. Absalon, K. G. McLure, and M. B. Kastan, "Regulation of p53 translation and induction afterDNAdamage by ribosomal protein L26 and nucleolin," Cell, vol. 123, no. 1, pp. 49-63, 2005.
31. S. A. Tenenbaum, P. J. Lager, C. C. Carson, and J. D. Keene, "Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays," Methods, vol. 26, no. 2, pp. 191-198, 2002.
32. I. Fierro-Monti and M. B. Mathews, "Proteins binding to duplexed RNA: one motif, multiple functions," Trends in Biochemical Sciences, vol. 25, no. 5, pp. 241-246, 2000.
33. Y. H. Xu and G. A. Grabowski, "Molecular cloning and characterization of a translational inhibitory protein that binds to coding sequences of human acid beta-glucosidase and other mRNAs,"Molecular Genetics andMetabolism, vol. 68, no. 4, pp. 441-454, 1999.
34. M. K. Merrill and M. Gromeier, "The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site," Journal of Virology, vol. 80, no. 14, pp. 6936-6942, 2006.
35. L. M. Parker, I. Fierro-Monti, and M. B. Mathews, "Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase," Journal of Biological Chemistry, vol. 276, no. 35, pp. 32522-32530, 2001.
36. B. Tian, P. C. Bevilacqua, A. Diegelman-Parente, and M. B. Mathews, "The double-stranded-RNA-binding motif: interference and much more," Nature Reviews Molecular Cell Biology, vol. 5, no. 12, pp. 1013-1023, 2004.
37. T. W. Reichman, A. M. Parrott, I. Fierro-Monti et al., "Selective regulation of gene expression by nuclear factor 110, a member of the NF90 family of double-stranded RNA-binding proteins," Journal of Molecular Biology, vol. 332, no. 1, pp. 85-98, 2003.
38. T. R. Hartman, S. Qian, C. Bolinger, S. Fernandez, D. R. Schoenberg, and K. Boris-Lawrie, "RNA helicase A is necessary for translation of selectedmessenger RNAs," Nature Structural and Molecular Biology, vol. 13, no. 6, pp. 509-516, 2006.
39. T. W. Reichman and M. B. Mathews, "RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110," RNA, vol. 9, no. 5, pp. 543-554, 2003.
40. V. Neplioueva, E. Y. Dobrikova, N. Mukherjee, J. D. Keene, and M. Gromeier, "Tissue type-specific expression of the dsRNAbinding protein 76 and genome-wide elucidation of its target mRNAs," PLoS ONE, vol. 5, no. 7, Article ID e11710, 2010.
41. C. G. Lee, T. Eki, K. Okumura et al., "The human RNA helicase A (DDX9) genemaps to the prostate cancer susceptibility locus at chromosome band 1q25 and its pseudogene (DDX9P) to 13q22, respectively," Somatic Cell and Molecular Genetics, vol. 25, no. 1, pp. 33-39, 2000.
42. S. Zhang, P. Hemmerich, and F. Grosse, "Werner syndrome helicase (WRN), nuclear DNA helicase II (NDH II) and histone γH2AX are localized to the centrosome," Cell Biology International, vol. 31, no. 10, pp. 1109-1121, 2007.
43. S. Zhang, B. Schlott, M. Gorlach, and F. Grosse, "DNAdependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner," Nucleic Acids Research, vol. 32, no. 1, pp. 1-10, 2004.
44. K. H. Vousden and C. Prives, "P53 and prognosis: new insights and further complexity," Cell, vol. 120, no. 1, pp. 7-10, 2005.